Simplex Trading
RPRX icon

Simplex Trading’s Royalty Pharma RPRX Stock Holding History

Simplex Trading’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,109
Closed -$399K – 9996
2025
Q4 		$352K Buy
+9,109
New +$347K ﹤0.01% 3653
2024
Q2 		– Sell
-6,672
Closed -$185K – 9654
2024
Q1 		$202K Sell
6,672
-27,943
-81% -$824K ﹤0.01% 4858
2023
Q4 		$972K Sell
34,615
-12,897
-27% -$354K ﹤0.01% 3025
2023
Q3 		$1.29M Buy
47,512
+20,816
+78% +$618K ﹤0.01% 2440
2023
Q2 		$820K Buy
+26,696
New +$904K ﹤0.01% 2793
2022
Q4 		– Sell
-892
Closed -$37.2K – 10232
2022
Q3 		$35K Buy
+892
New +$38.1K ﹤0.01% 6896
2022
Q1 		– Sell
-12,798
Closed -$503K – 11250
2021
Q4 		$510K Buy
12,798
+11,774
+1,150% +$457K ﹤0.01% 3776
2021
Q3 		$43K Sell
1,024
-705
-41% -$27.4K ﹤0.01% 7697
2021
Q2 		$70K Buy
1,729
+1,303
+306% +$55.4K ﹤0.01% 7213
2021
Q1 		$18K Buy
+426
New +$20.2K ﹤0.01% 7547
2020
Q3 		– Sell
-76
Closed -$3.26K – 8395
2020
Q2 		$3K Buy
+76
New +$3.76K ﹤0.01% 7176

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Simplex Trading's RPRX Position: Q1 2026 in Review

Simplex Trading sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 9,109 shares — an estimated $399K sold.

Simplex Trading first reported a position in RPRX in Q2 2020 and held it in 11 quarters. The position peaked at $1.29M in Q3 2023. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Simplex Trading reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 9,109 Royalty Pharma shares in Q1 2026, an estimated $399K.
  • Simplex Trading first reported a position in Royalty Pharma in Q2 2020 and held it in 11 quarters.
  • Simplex Trading's Royalty Pharma position peaked at $1.29M in Q3 2023.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.